Israel’s Teva in pact with Launch Therapeutics for asthma drug
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
HQ Team April 1, 2024: The surge in neurological and neurodevelopmental conditions over the past decade has raised concerns among medical experts, who
HQ Team April 1, 2024: Preventing the spread of sexually transmitted infections (STIs) might soon be as simple as taking a couple of
HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering
HQ Team March 29, 2024:Five people have died and 143 hospitalised in Japan after consuming health supplements. The Japanese health ministry has warned
HQ Team March 29, 2024: The last few years have seen many innovative devices that help in monitoring blood sugar without finger pricks.
HQ Team March 29, 2024: Bristol Myers Squibb’s final stage clinical trials for its Zeposia oral drug, to treat moderate to severe Crohn’s
HQ Team March 28, 2024: US regulator, the FDA has approved Gilead Sciences, Inc.’s supplemental new drug application for treating chronic hepatitis B
HQ Team March 28, 2024: Australia’s carbon offset scheme, a central feature of climate policy in the country for two decades, to regenerate